KEW Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Out of Business

KEW General Information

Description

Operator of a genomic profiling company designed to revolutionize cancer care. The company provides therapeutic options based on an individual patient's tumor genetic profile for identifying genetic variants and matching them with targeted therapies in solid tumors, enabling molecular labs to expand oncology precision medicine programs for better treatment decisions and quality patient care.

Contact Information

Website
www.kewinc.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 303 Wyman Street
  • Office Suite 349
  • Waltham, MA 02451
  • United States
+1 (855)
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • 303 Wyman Street
  • Office Suite 349
  • Waltham, MA 02451
  • United States
+1 (855)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KEW Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 29-Dec-2023 Completed Out of Business
3. Secondary Transaction - Private 01-Nov-2020 Completed Generating Revenue
2. Later Stage VC (Series B) 12-Jan-2015 $16.8M $32.9M Completed Generating Revenue
1. Later Stage VC (Series A) 24-Feb-2014 $16.1M $16.1M Completed Generating Revenue
To view KEW’s complete valuation and funding history, request access »

KEW Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view KEW’s complete cap table history, request access »

KEW Patents

KEW Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2012225666-A1 Personalized medical management system, networks, and methods Inactive 04-Mar-2011
EP-2681709-A2 Personalized medical management system, networks, and methods Inactive 04-Mar-2011
EP-2681709-A4 Personalized medical management system, networks, and methods Inactive 04-Mar-2011
US-20120231959-A1 Personalized medical management system, networks, and methods Inactive 04-Mar-2011
WO-2012122127-A2 Personalized medical management system, networks, and methods Inactive 04-Mar-2011 G16B50/00
To view KEW’s complete patent history, request access »

KEW Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KEW Acquisitions (1)

KEW’s most recent deal was a Merger/Acquisition with Ship-Elec (Electrical Wholesalers). The deal was made on 13-Apr-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ship-Elec (Electrical Wholesalers) 13-Apr-2016 Merger/Acquisition Distributors/Wholesale
To view KEW’s complete acquisitions history, request access »

KEW FAQs

  • When was KEW founded?

    KEW was founded in 2009.

  • Where is KEW headquartered?

    KEW is headquartered in Waltham, MA.

  • What is the size of KEW?

    KEW has 19 total employees.

  • What industry is KEW in?

    KEW’s primary industry is Biotechnology.

  • Is KEW a private or public company?

    KEW is a Private company.

  • What is KEW’s current revenue?

    The current revenue for KEW is .

  • How much funding has KEW raised over time?

    KEW has raised $32.9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process